Sara Caprodossi
Overview
Explore the profile of Sara Caprodossi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santoni G, Caprodossi S, Farfariello V, Liberati S, Gismondi A, Amantini C
ISRN Urol
. 2012 Apr;
2012:458238.
PMID: 22523714
The progression of normal cells to a tumorigenic and metastatic state involves the accumulation of mutations in multiple key signaling proteins, encoded by oncogenes and tumor suppressor genes. Recently, members...
2.
Morelli M, Nabissi M, Amantini C, Farfariello V, Ricci-Vitiani L, Di Martino S, et al.
Int J Cancer
. 2012 Apr;
131(7):E1067-77.
PMID: 22492283
Malignant transformation of cells resulting from enhanced proliferation and aberrant differentiation is often accompanied by changes in transient receptor potential vanilloid (TRPV) channels expression. In gliomas, recent evidence indicates that...
3.
Farfariello V, Amantini C, Nabissi M, Morelli M, Aperio C, Caprodossi S, et al.
Pediatr Allergy Immunol
. 2011 May;
22(4):419-23.
PMID: 21535180
T helper (T(H) )-17 lymphocytes are characterized by the expression of many regulatory cytokines, including IL-17A and IL-22, but at present no clinical data are available on the expression of...
4.
Caprodossi S, Amantini C, Nabissi M, Morelli M, Farfariello V, Santoni M, et al.
Carcinogenesis
. 2011 Feb;
32(5):686-94.
PMID: 21310942
Capsaicin (CPS) has been found to exhibit either tumor promoting or suppressing effects, many of which are mediated by the specific transient receptor potential vanilloid type-1 (TRPV1). Herein, we provide...
5.
Kalogris C, Caprodossi S, Amantini C, Lambertucci F, Nabissi M, Morelli M, et al.
Histopathology
. 2010 Nov;
57(5):744-52.
PMID: 21083604
Aims: To evaluate the expression of transient receptor potential vanilloid type-1 channel protein (TRPV1) in normal and neoplastic urothelial tissues and to correlate TRPV1 expression with clinicopathological parameters and disease-specific...
6.
Nabissi M, Morelli M, Amantini C, Farfariello V, Ricci-Vitiani L, Caprodossi S, et al.
Carcinogenesis
. 2010 Jan;
31(5):794-803.
PMID: 20093382
The aim of this study was to investigate the expression and function of the transient receptor potential vanilloid 2 (TRPV2) in human glioma cells. By Real-Time-PCR and western blot analysis,...
7.
Amantini C, Ballarini P, Caprodossi S, Nabissi M, Morelli M, Lucciarini R, et al.
Carcinogenesis
. 2009 Jun;
30(8):1320-9.
PMID: 19502594
Herein, we provide evidence on the expression of transient receptor potential vanilloid type 1 (TRPV1) on human urothelial cancer (UC) cells and its involvement in the apoptosis induced by the...
8.
Caprodossi S, Lucciarini R, Amantini C, Nabissi M, Canesin G, Ballarini P, et al.
Eur Urol
. 2007 Nov;
54(3):612-20.
PMID: 17977643
Objective: To evaluate the expression of transient receptor potential vanilloid type 2 (TRPV2) in normal human bladder and urothelial carcinoma (UC) tissues. Methods: Bladder specimens were obtained by transurethral resection...
9.
Caprodossi S, Galluzzi L, Biagetti S, Della Chiara G, Pelicci P, Magnani M, et al.
Oncol Res
. 2006 Aug;
16(3):157-66.
PMID: 16925116
Acute promyelocytic leukemia (APL) is a subtype of myeloid leukemia characterized by the chromosomal translocation t(15:17) that leads to the expression of promyelocytic leukemia/retinoic acid receptor-alpha (PML/ RARalpha) oncofusion protein....
10.
Caprodossi S, Pedinotti M, Amantini C, Santoni G, Minucci S, Pelicci P, et al.
Mol Biotechnol
. 2005 Jul;
30(3):231-8.
PMID: 15988048
Acute promyelocytic leukemia (APL) is a human cancer generated by a chromosomal translocation t(15;17) involving the promyelocytic leukemia (PML) and retinoic acid receptor alpha (RARalpha) genes. The PML/RARalpha oncoprotein expressing...